Negroni E, Chigorno V, Tettamanti G, Sonnino S
Department of Medical Chemistry and Biochemistry, Medical School, University of Milan, Italy.
Glycoconj J. 1996 Jun;13(3):347-52. doi: 10.1007/BF00731466.
An efficiency assessment of a ganglioside assay procedure was carried out on human serum gangliosides from healthy subjects of different sex and age. The analysis of the gangliosides, extracted with chloroform/methanol and purified by lipid partitioning, ion exchange column chromatographic separation and desalting procedures as described by Senn et al. (1989) Eur J Biochem 181: 657-62, was performed by HPTLC followed by densitometric quantification. The yield of the procedure, expressed as radioactivity recovery, was determined by adding GM3 ganglioside, tritium labelled at the sialic acid acetyl group and at the C3 position of sphingosine, to the lyophilized serum or by associating it with the serum lipoproteins. In spite of the fact that the extraction and purification procedures were performed exactly as described we found the radioactivity recovery to be variable (25-50%) and much lower than that proposed. Much of the radioactivity was found in the organic phase after lipid partitioning, whilst all the ganglioside purification steps led to some further loss. After the introduction of some modifications to the procedure the recovery improved, reaching 67-79%. The analyses on 33 samples of 5 ml showed a human serum ganglioside content of about 10 nmol ml-1 (as corrected for the recovery), and confirmed that GM3 ganglioside is the main component of the total serum ganglioside mixture.
对来自不同性别和年龄健康受试者的人血清神经节苷脂进行了神经节苷脂测定程序的效率评估。按照Senn等人(1989年,《欧洲生物化学杂志》181: 657 - 62)所述,用氯仿/甲醇提取并通过脂质分配、离子交换柱色谱分离和脱盐程序纯化的神经节苷脂,采用高效薄层层析(HPTLC)随后进行光密度定量分析。该程序的产率以放射性回收率表示,通过向冻干血清中添加在唾液酸乙酰基和鞘氨醇C3位置标记有氚的GM3神经节苷脂或使其与血清脂蛋白结合来确定。尽管提取和纯化程序完全按照所述进行,但我们发现放射性回收率变化不定(25% - 50%)且远低于预期。脂质分配后,大部分放射性存在于有机相中,而所有神经节苷脂纯化步骤都会导致进一步损失。对该程序进行一些修改后,回收率提高到了67% - 79%。对33个5毫升样本的分析表明,人血清神经节苷脂含量约为10纳摩尔/毫升(经回收率校正),并证实GM3神经节苷脂是总血清神经节苷脂混合物的主要成分。